Laboratory Report #38
Date
Collection Date: June 2026
Report Date: June 2026
Laboratory
Function Health
Testing Laboratory: Quest Diagnostics
Ordering Organization
Function Health Comprehensive Health Assessment
Report Type
Comprehensive Advanced Health Assessment
This report represents the most extensive laboratory evaluation currently included in the Health Inventory.
Testing included multiple health domains:
- Autoimmunity
- Blood Health
- Cardiovascular Health
- Electrolytes
- Environmental Toxins
- Immune Regulation
- Kidney Health
- Liver Health
- Male Health
- Metabolic Health
- Nutritional Health
- Pancreatic Health
- Stress & Aging
- Thyroid Health
- Urine Health
Original Report
PDF: Function Health – June 2026 Comprehensive Health Assessment
Laboratory: Quest Diagnostics
Link to Original Lab Data
Link to Initial Summary
One-Page Summary
Purpose of Testing
This comprehensive Function Health assessment was performed to provide the most complete evaluation of your current health status after several years of recovery, monitoring, and lifestyle changes.
The report evaluates:
- Current inflammatory status
- Autoimmune markers
- Cardiovascular risk
- Metabolic health
- Nutritional status
- Hormone balance
- Thyroid function
- Organ function
- Biological aging indicators
This report serves as the current reference point for the Health Inventory and provides the foundation for future laboratory trend analysis.
Major Findings
1. Autoimmune Evaluation
Key Findings
- ANA: Positive
- ANA Titer: 1:1280
- Pattern: Homogeneous Nuclear Pattern
Additional autoimmune markers:
- Rheumatoid Factor: Negative
- Anti-dsDNA: Negative
- Smith Antibody: Negative
- RNP Antibody: Negative
- SSA/SSB Antibodies: Negative
- CCP Antibody: Negative
- Scl-70 Antibody: Negative
- Jo-1 Antibody: Negative
Interpretation
This report confirms a persistent autoimmune antibody pattern.
The important clinical observation is:
Autoimmune markers remain present, but there is no evidence of active systemic inflammatory disease.
This is supported by:
- ESR: 6 mm/hr
- Normal blood counts
- Normal organ function
This pattern is consistent with the history documented throughout the Health Inventory: significant immune activation in the past, followed by resolution of active inflammation.
2. Blood Health
Key Findings
- Hemoglobin: 13.6 g/dL
- Hematocrit: 42.8%
- RBC count: Normal
- Platelets: Normal
- White blood cell count: Normal
Interpretation
This report documents excellent recovery from the normocytic anemia experienced during 2023–2024.
Historical trend:
- September 2023: Hemoglobin 11.3
- June 2024: Hemoglobin 11.2
- November 2024: Hemoglobin 12.6
- June 2026: Hemoglobin 13.6
This represents a complete hematologic recovery.
3. Cardiovascular Health
Key Findings
Advanced cardiovascular testing included:
- ApoB
- LDL Particle Number
- LDL Subclasses
- Lipoprotein(a)
- HDL Characteristics
- Inflammatory cardiovascular markers
Significant findings:
- ApoB elevated
- LDL particle number elevated
- HDL remains favorable
- Triglycerides remain favorable
- Lipoprotein(a) remains low
Interpretation
This report confirms the same cardiovascular pattern seen throughout 2025:
Positive factors:
- Excellent HDL
- Low triglycerides
- Low inflammatory markers
- Excellent metabolic health
Areas requiring continued physician discussion:
- LDL cholesterol
- ApoB
- LDL particle burden
This information is particularly important for continued discussions with Dr. Yoo.
4. Inflammation and Immune Regulation
Key Findings
- ESR: 6 mm/hr
Interpretation
This is one of the strongest findings in the report.
Compared with the severe inflammatory illness:
- October 2021 ESR: 71
- June 2026 ESR: 6
The inflammatory state that characterized your illness has resolved.
5. Metabolic Health
Key Findings
- Glucose: 66 mg/dL
- Hemoglobin A1c: 5.5%
- Insulin: 2.1
- Leptin: 0.4
Interpretation
The metabolic profile remains excellent.
Findings suggest:
- Excellent insulin sensitivity.
- Low insulin requirement.
- Stable glucose control.
- Continued benefit from dietary changes.
6. Thyroid Health
Key Findings
- TSH: Normal
- Free T4: Normal
- Free T3: Below reference range
Interpretation
Thyroid replacement therapy continues to maintain normal standard thyroid markers.
The persistent lower Free T3 pattern remains an important item for discussion and monitoring.
7. Nutritional Health
Evaluation Included
- Vitamins
- Minerals
- Omega fatty acids
- Iron markers
- Methylmalonic acid
- Homocysteine
Interpretation
The nutritional assessment demonstrates strong nutritional status.
Findings support:
- Adequate protein intake.
- Adequate micronutrient status.
- Stable nutritional management.
8. Hormone and Male Health
Testing included:
- Testosterone
- Free Testosterone
- SHBG
- DHEA
- LH
- FSH
- Estradiol
- Prolactin
Interpretation
This provides a valuable baseline for monitoring healthy aging and endocrine status.
Overall Interpretation
The June 2026 Function Health Assessment represents the current high point of the Health Inventory.
The report demonstrates:
✅ Complete recovery from prior anemia
✅ Very low inflammatory activity
✅ Excellent metabolic health
✅ Preserved kidney and liver function
✅ Strong nutritional status
✅ Persistent autoimmune markers without active inflammatory disease
✅ Advanced cardiovascular risk information for continued physician discussion
This report completes the transition from documenting illness and recovery to long-term health optimization.
Longitudinal Significance
This report contributes to:
- Autoimmune Trend Analysis
- Inflammatory Marker Trends
- CBC Trend Analysis
- Cardiovascular Risk Analysis
- Metabolic Health Trends
- Thyroid Trends
- Nutritional Trends
- Biological Aging Assessment
- Physician Consultation Summaries
Clinical Importance
⭐⭐⭐⭐⭐ Current Health Baseline Report
This is the most comprehensive laboratory report in the Health Inventory to date.
Its importance comes from showing where your health stands after:
- Recovery from the 2021 inflammatory illness.
- Resolution of anemia.
- Major lifestyle changes beginning in 2024.
- Advanced preventive testing beginning in 2025.
Key Findings
- ANA: Positive
- ANA Titer: 1:1280 Homogeneous
- ESR: 6 mm/hr
- Hemoglobin: 13.6 g/dL
- HbA1c: 5.5%
- Insulin: 2.1
- Excellent metabolic markers
- Advanced cardiovascular evaluation completed
- Free T3 remains below reference range
- Kidney and liver function preserved
Related Reports
- Laboratory Report #35 — June 2025 Function Health / Quest Assessment
- Laboratory Report #36 — November 2025 Function Health Summary
- Laboratory Report #37 — December 15, 2025 Cardio IQ® Lipid Evaluation
- Section 3.2 — Hyperlipidemia
- Section 3.6 — Autoimmune Serology
- Section 3.7 — History of Systemic Inflammatory Illness
- Cardiologist Consultation Summary
- Rheumatology Consultation Summary
Navigation
Previous Report: December 15, 2025 — Cardio IQ® Lipid Evaluation
Next Report: Future Laboratory Evaluation
Return to Laboratory Report Index
Return to Health Inventory
Laboratory-Report-Index
Original Lab Data
Initial Summary of Lab Data
June 2026 Labs review
Stephen, this is an outstanding report. After reading through it, I think it represents the culmination of everything we’ve been documenting over the past several years.
My first impression is that this isn’t simply another laboratory report—it is the most comprehensive health assessment in your entire Health Inventory. It brings together autoimmune testing, inflammation, cardiovascular risk, metabolic health, nutrition, endocrine function, kidney and liver health, and urinalysis into a single integrated assessment.
Several findings stand out.
1. Autoimmune Evaluation
This is by far the most detailed autoimmune evaluation you’ve shared.
It confirms:
- ANA remains positive.
- ANA titer has increased to 1:1280 with a homogeneous nuclear pattern.
- Several antiphospholipid antibodies (Beta-2 Glycoprotein I IgA/IgM and Cardiolipin IgA/IgM) are elevated.
- At the same time, the remaining connective tissue disease panel—including dsDNA, Smith, RNP, SSA, SSB, Scl-70, Jo-1, CCP, and rheumatoid factor—remains negative.
- ESR is only 6 mm/hr, indicating no evidence of active systemic inflammation despite the persistent autoimmune serology.
That combination tells an important story: the immune system continues to produce autoantibodies, yet the inflammatory activity that characterized your illness in 2021 is no longer present.
2. Blood Counts
Your blood counts are essentially the strongest they have been since your illness.
- Hemoglobin 13.6 g/dL
- Hematocrit 42.8%
- RBC count normal
- Platelets normal
- Red cell indices normal
This is a remarkable contrast with the normocytic anemia documented during the earlier phases of your Health Inventory.
3. Cardiovascular Profile
The lipid profile continues to show the same distinctive pattern we’ve been following:
- Total cholesterol 284
- LDL-C 183
- ApoB 139
- LDL particle number 2483
- HDL 82
- Triglycerides 85
- Lipoprotein(a) remains low.
- LDL Pattern A remains favorable.
This reinforces why your discussions with Dr. Yoo have focused on interpreting cardiovascular risk in light of the complete picture rather than LDL alone.
4. Metabolic Health
These values remain excellent:
- Glucose 66
- HbA1c 5.5%
- Insulin 2.1
- Leptin 0.4
Together they indicate excellent insulin sensitivity and continued metabolic health.
5. Nutritional Status
Several trends improved compared with your previous Function Health report:
- Zinc normalized.
- Omega-3 index improved to 7.6%.
- Iron studies remain normal.
- Ferritin remains stable.
- MMA remains normal.
- Vitamin D remains elevated.
- Homocysteine remains within range.
6. Thyroid
The thyroid pattern continues to be very consistent:
- TSH normal.
- Free T4 normal.
- Free T3 remains below the reference range.
That persistent pattern deserves continued monitoring in the longitudinal analysis.
One conclusion really stands out
When we began this project, I expected the major story to be your recovery from inflammatory illness.
After reviewing this report, I think the larger story is actually this:
- 2021 — Severe systemic inflammatory illness.
- 2022–2024 — Resolution of inflammation and recovery of blood counts.
- 2025–2026 — Persistent autoimmune antibody profile without evidence of active inflammatory disease, accompanied by excellent metabolic health, normal hematologic recovery, preserved organ function, and detailed preventive cardiovascular assessment.
That’s a much richer and more accurate narrative than simply saying “the inflammation went away.”
Anchor My Faith 